What Is Drug Delivery
The appropriate administration of drugs through various routes in the body for the purpose of improving health.
It is highly interdisciplinary Field and It is not a young Field also. It has recently evolved to take into consideration Because of Its Increasing Market.
The global top 10 drug delivery technologies market is expected to grow from $43.8 billion in 2009 to $81.5 billion in 2015, at an estimated CAGR of 11% from 2010 to 2015. Prominent industry participants include Elan, Biovail, Nektar, Alkermes & Nektar.
Top 10 Drug Delivery Technologies
- Time release technologies
- Targeted delivery
- Aerosol technology
- Encapsulation technology
- Topical formulations
- Injectables
- Trandermal patch
- Implant technology
- Liposomal drug delivery
- PEGlyation technology
Top 10 Drug Delivery Technologies Market To Grow Exponentially
The increasing demand for effective delivery of novel biopharmaceuticals is driving the growth of the global top 10 drug delivery technologies market. Patent expirations of drugs, need for faster drug development and greater drug approvals are further fuelling market growth. The global top 10 drug delivery technologies market is expected to grow from $43.8 billion in 2009 to $81.5 billion in 2015, at an estimated CAGR of 11% from 2010 to 2015. The time release technologies market commands the largest share around 19% of the overall top 10 drug delivery technologies market, owing to immense popularity of once-daily formulations.
Drug delivery technologies are revenue boosters for the pharmaceutical industry as they enhance drug life cycle in the market by extending patent rights, adding a competitive edge to the drug by enhancing their safety and efficacy. Further, expansion of the applications of non conventional modes of drug delivery such as pulmonary, nasal and transdermal in disease conditions other than respiratory and skin, especially in chronic disease conditions such as diabetes, CNS are also boosting the market. In addition, innovations such as microneedle transdermal patches and novel intelligent inhalers are also adding to the market growth. However, recent drug failures such as Exubera by Pfizer is a hindrance for the market.
Prominent industry participants include Elan, Biovail, Nektar and Alkermes. Pure drug delivery technology providers are gradually shifting towards specialty pharmaceuticals with focus on CNS and Cancer. Further, industry players are focusing on developing alternatives that are not only safe and effective but also are convenient in terms of drug administration and dosing regimen.
Currently, market players are focusing in the development and commercialization of new drugs through agreements and collaborations which therefore accounted for the highest share of the total competitive developments in the global top 10 drug delivery technologies market from 2007 to June 2010.
No comments:
Post a Comment